MMI pioneers Symani Surgical System in first US cases
The FDA granted de novo classification to the Symani Surgical System for soft tissue manipulation in microsurgery in April 2024.
The FDA granted de novo classification to the Symani Surgical System for soft tissue manipulation in microsurgery in April 2024.
Klineo plans to expand its AI platform to include all cancers in France by the end of 2024, and eventually other countries and diseases.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of new treatment...
Hyperfine starts enrolment in portable imaging workflow study
Acarix starts clinical workflow study for its AI-powered cardiac diagnostic
Cleerly touts new data for AI cardiovascular software
Moderna’s Phase III Covid-19 vaccine trial meets primary endpoints